Biotech News
NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Has $7.8 Million in Financing for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD
ARCH Dental + Aesthetics launches a new website, designed to provide comprehensive information on cosmetic and dental implant services, aimed at improving patient engagement and education. The site offers intuitive navigation, mobile-friendly access, and
Revolutionary sonic-based transdermal system joins Juventix's lineup of non-invasive and minimally invasive PRP and biologics delivery solutions, offering safe and effective access to regenerative therapies for a broader range of providers.
$NRXP Closing $7.8 Million in Financing for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute Treatment Model and Leading Investigative Site
Phoenix Implant Clinic has introduced a new cost page to provide clear, upfront dental implant pricing. This transparency initiative addresses common financial concerns, outlines cost-influencing factors, and supports patient empowerment. The clinic, led
Sigla Sciences, Metli, Solem Global, Advient Advisors, Rapid Commercialization Partners, and Presley Global Management formally unite under a new alliance: Sumis Partners.
Koplon Implant & Family Dentistry, a premier dental care provider serving the Birmingham area and beyond, has been nationally recognized as a Neodent Elite practice—an honor awarded to fewer than 12 practices across the United States. This exclusive desig
$NRXP NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP): Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties
NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties
Cadrenal Therapeutics, Inc. (Stock Symbol: CVKD) $CVKD Tecarfarin Anticoagulant Reduces Drug on Drug Interactions Which Pose a Major Issue with Warfarin. Successful Phase III Could Enhance Liquidity and Quickly Attract Large Institutional Investors.
$BEAT Clinical Endpoints Successfully Met in Pivotal Study, Plus FDA Clearance for At-Home, High-Fidelity Heart Monitoring System.
$NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties. NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
TORONTO - -- Meditech International Inc. (BIOFLEX), the makers of world-renowned Red Light and Laser Therapy (RLT) systems, is pleased to continue/extend its official sponsorship as proud Red Light Therapy Provider of the Los Angeles Rams. This ongoing...
Experienced, Recognized Orthopedic Business and Surgical Professionals to Help Identify and Evaluate Strategic Opportunities
MIAMI - -- First Choice Neurology is proud to announce a groundbreaking partnership with NeuroDiscovery AI (NDAI), a national leader in artificial intelligence, data analytics, and clinical dashboarding for neurology. This strategic collaboration brings..
$300 Million Set up in Milestones for $NRXP on Tiered Double-Digit Royalties
$BEAT Forms Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care. HeartBeam, Inc. (Stock Symbol: BEAT)
NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties
NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP): License and Distribution Terms Set for Lucrative Suicide Depression Treatment; $31 Price Target from Respected Investment Analyst D. Boral Capital